Review product details, clear protocols, COAs, pricing, and availability for popular peptides like Retatrutide, Tirzepatide, BPC-157, TB-500, GHK-Cu, and more (17 peptides).
Submit your inquiry variables directly to the warehouse network node for immediate material documentation and current wholesale tier charts.
An experimental 39-amino acid peptide targeting three distinct metabolic pathways: GIP, GLP-1, and glucagon receptors. It dramatically shifts fat-burning kinetics by combining incretin hormone action with direct glucagon-mediated energy expenditure acceleration.
A synthetic linear peptide configured to target both GIP and GLP-1 receptors simultaneously. By utilizing dual-incretin action, it achieves significantly higher insulinotropic signaling efficiency than single GLP-1 analogues.
A selective, single-receptor GLP-1 agonist structurally optimized with a C20 fatty diacid chain. This specific modification protects the peptide from rapid degradation by the DPP-4 enzyme.
A stable gastric pentadecapeptide composed of 15 amino acids. It acts as a highly resilient structural cell protector, driving rapid soft-tissue recovery by directly upregulating vascular endothelial growth factor (VEGF).
A synthetic fragment modeling the active center of the Thymosin Beta-4 protein. It dictates structural cellular motility by binding directly to G-actin, accelerating systematic tissue remodeling across the entire body.
The definitive synergistic dual-compound layout pairing BPC-157 and TB-500. This configuration targets two completely separate cellular repair tracks concurrently, maximizing tissue regeneration acceleration rules.
A naturally occurring copper-complexed tripeptide that acts as a primary signaling engine for extracellular matrix remodeling. It alters gene transcription loops to balance collagen and elastin synthesis.
A proprietary compounding array pairing high-purity GHK-Cu with active intracellular glutathione and stabilized antioxidant complexes.
A complex formulation linking BPC-157, GHK-Cu, TB-500, and the anti-inflammatory tripeptide KPV.
A synthetic heptapeptide derived from the ACTH 4-10 fragment. It focuses entirely on central nervous system signaling by directly upregulating Brain-Derived Neurotrophic Factor (BDNF) transcription loops.
A synthetic heptapeptide modeled after the immunomodulatory peptide Tuftsin. It functions as a safe anxiolytic by altering monoamine levels and preventing enkephalin degradation.
A short, synthetic peptide bioregulator consisting of three amino acids. Its tiny molecular weight allows it to penetrate cellular and nuclear membranes to interact directly with DNA strands.
A synthetic 44-amino acid peptide modeling native GHRH, modified with a trans-3-hexenoyl group to maximize stability. It selectively cuts through deep, stubborn visceral fat mass.
An innovative 16-amino acid peptide encoded directly within the mitochondrial 12S rRNA gene. It upregulates the AMPK pathway to turn cells into highly efficient glucose-burning engines.
A selective, synthetic pentapeptide ghrelin receptor agonist. It triggers clean, pulsatile waves of growth hormone release without causing unwanted spikes in cortisol or prolactin.
A naturally occurring regulatory nonapeptide isolated from cerebral fluids. It acts on pre-synaptic neuro-regulatory centers to stabilize sleep-wake architecture and optimize delta-wave brain health.
A synthetic pineal gland-derived tetrapeptide built to bypass the Hayflick limit of cellular death. It interacts directly with chromosomal endpoints to activate telomerase enzymes.